More on MLTX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-6.9% Growth)
- Ratings (6.7 Score)

Upcoming Events

- Earnings (8/12/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

MoonLake Immunotherapeutics (NQ:MLTX)
Delayed: 19.21 +0.02 (0.10%)
Prev. Close $19.19  
Open$19.50 
52 Wk High$ 
52 Wk Low$ 
Day High$19.80 
Day Low$19.00 
P/E N/A  
EPS$ 
Volume774,519 

Friends, Peers and Foes (?): ACAD, BCRX, INSM, JAZZ, LEGN (more...)

Jun 21, 2026 05:00 PM MoonLake reports week 52 phase 3 trial data for skin drug sonelokimab
Jun 21, 2026 05:00 PM MoonLake Announces Week 52 Results of Sonelokimab from its Phase 3 VELA Program in Hidradenitis Suppurativa and Confirms Investor Day on June 22, 2026
Jun 18, 2026 06:45 PM Form 4 MoonLake Immunotherapeut For: Jun 17 Filed by: Bodenstedt Matthias
Jun 18, 2026 06:45 PM Form 4 MoonLake Immunotherapeut For: Jun 17 Filed by: Phillips Andrew John
Jun 18, 2026 06:45 PM Form 4 MoonLake Immunotherapeut For: Jun 17 Filed by: Loy Spike
Jun 18, 2026 06:45 PM Form 4 MoonLake Immunotherapeut For: Jun 17 Filed by: Moukheibir Catherine
Jun 18, 2026 06:45 PM Form 4 MoonLake Immunotherapeut For: Jun 17 Filed by: Xavier Ramnik
Jun 17, 2026 06:15 PM Form 4 MoonLake Immunotherapeut For: Jun 15 Filed by: Reich Kristian
Jun 15, 2026 05:14 PM Form 144 MoonLake Immunotherapeut Filed by: Reich Kristian
Jun 9, 2026 04:30 PM Form 8-K MoonLake Immunotherapeut For: Jun 04
View All Articles

Entities mentioned with MLTX

View All Entities